查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
2011687

大腿穿刺器材市场：依器械类型、鞘套尺寸、材质、应用和最终用户划分－2026-2032年全球市场预测

Femoral Access Devices Market by Device Type, Sheath Size, Material, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，大腿入路装置市场价值将达到 21.7 亿美元，到 2026 年将成长至 24.1 亿美元，到 2032 年将达到 46.6 亿美元，复合年增长率为 11.49%。

主要市场统计数据
基准年 2025 21.7亿美元
预计年份：2026年 24.1亿美元
预测年份 2032 46.6亿美元
复合年增长率 (%) 11.49%

概述不断发展的股动脉通路装置市场，其中临床需求、装置创新和营运重点塑造了策略选择。

股动脉入路器械市场正经历持续的演变，其驱动力包括手术复杂性的增加、器械的创新以及医疗系统需求的不断增长。临床医生越来越需要能够提高手术精准度并最大限度减少併发症的工具，而製造商也在调整产品系列和材料以满足这些期望。同时，不断变化的报销机制、品质指标和医院筹资策略也在影响门诊手术中心、诊所和医院的采购行为。因此，整个价值链上的相关人员必须平衡临床优先事项和营运效率，以改善患者预后并减少术中和术后併发症。

不断发展的临床实践、聚合物和涂层技术的创新以及医疗保健服务格局的变化，是如何重新定义医疗设备设计重点和采购实践的？

股动脉入路器械领域正经历一系列变革，其驱动力包括临床实践的转变、技术的进步以及对手术全期安全性的日益重视。在心血管外科、神经外科、放射外科和血管外科领域，外科医师越来越多地采用微创手术方式，因此，器械的设计重点也随之转向体积更小、止血控制更佳、且能与影像和导航系统无缝整合的器械。因此，设计重点正转向亲水涂层、高度适应性的阀门系统以及能够减少动脉损伤并与更多手术器械相容的鞘套形状。

评估 2025 年关税政策和贸易趋势的变化将如何重塑筹资策略、价格谈判和供应链韧性方面的决策。

2025年，贸易政策的变化和关税措施的实施，为采购股动脉通路装置及其组件的机构带来了新的复杂性。针对医疗设备进口、组件和聚合物原料的关税调整，改变了部分製造商和经销商的成本结构，尤其是那些供应链依赖跨境製造地。这些变化迫使下游相关人员重新评估其筹资策略、库存缓衝和供应商多元化，以降低成本突然上涨的风险。

高解析度分割分析揭示了设备结构、鞘套尺寸、临床应用、终端用户环境和材料科学如何共同推动其普及应用。

为了解细分市场的效能，必须详细检视器材类别、鞘套尺寸、临床应用、终端使用者环境和材料选择。这些因素都是独特采购逻辑和临床价值提案背后的驱动力。根据器械类型，市场可细分为扩张器、导管导引线、止血阀和导引鞘，并进行相应研究。在扩张器方面，多腔和单腔配置的差异会影响交换效率和器械相容性；而导管导引线的亚型，例如亲水性涂层、J型尖端和直型尖端，则决定了其导航特性和血管通路策略。止血阀的选择，从亲水阀到机械阀，直接影响出血控制和手术操作的可行性。导引鞘按10Fr及以上、6Fr及以下和7Fr至9Fr分类，反映了与手术器械的兼容性和血管损伤方面的考虑。

区域趋势和策略性洞察揭示了影响全球主要地区采用趋势的独特还款、监管和基础设施因素。

股动脉通路器械领域的区域趋势反映了美洲、欧洲、中东和非洲以及亚太地区医疗保健系统结构、法规环境和投资重点的差异。在美洲，成熟的介入性心臟病学和血管外科项目，加上健全的报销机制，支持了先进器械功能和打包服务模式的早期应用。该地区对临床结果和基于价值的采购的重视，促使供应商支持长期临床研究，以检验器械能够降低併发症率，并在真实临床环境中验证其性能。

这份竞争格局分析报告详细阐述了涂层、阀门设计和整合服务交付方面的创新如何影响供应商差异化和合作伙伴关係。

股动脉入路器材领域的竞争格局正在重塑，企业更加重视产品创新、策略伙伴关係和供应链的稳定性。领先的器械开发商正优先研发差异化技术，例如先进的亲水涂层、精密的止血阀设计以及旨在减少动脉损伤的优化鞘套形状，以赢得介入外科医生的支持。许多公司也在拓展服务范围，包括外科训练、手术流程清单和数据驱动的疗效支援。这些措施有助于加速产品推广应用，并提升临床提案。

制定可操作的策略重点，整合产品创新、製造韧性、与临床医生的合作以及灵活的合同，以确保可持续的市场领导地位。

产业领导企业应采取协作策略，将产品创新、供应链韧性和临床疗效证据结合。优先投资于能够显着减少血管损伤并提高器械操作性的材料和涂层技术，并将这些创新与严格的上市后数据收集相结合，以检验临床益处。在与以结果为导向的采购委员会和支付相关人员沟通时，证明併发症率降低和工作流程简化至关重要。

结合对临床医生的访谈、对监管和临床证据的审查以及情境分析，采用稳健的混合方法研究途径，可以产生检验的策略见解。

本研究整合了多项证据，以确保结论既有主要研究结果的支持，也有次要检验。主要资讯来源包括对循环系统、神经病学、放射学和血管外科介入临床医生、医院和门诊中心的采购和供应链经理以及医疗设备製造商的研发主管进行的结构化访谈。这些访谈旨在深入了解医疗医疗设备效能、采购重点、临床工作流程限制以及供应链薄弱环节等方面的实际问题。

透过整合核心研究成果并制定强调临床检验、供应链敏捷性和商业性可行性的策略蓝图，我们正在推动永续应用。

股动脉通路器材市场正处于技术进步、临床需求和商业策略交会的十字路口。材料和器材结构的进步使得更安全、更有效率的通路技术成为可能，而医疗保健格局和采购模式的改变正在改变器材的采购和部署方式。同时，贸易政策趋势和供应链压力凸显了製造敏捷性和商业性柔软性的必要性。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：大腿入路器材市场：依器材类型划分

  • 扩充器
    • 多流明
    • 单流明
  • 导管导引线
    • 亲水涂层
    • J 型尖端
    • 直尖
  • 止血瓣
    • 亲水阀
    • 机械阀
  • 导引鞘
    • 10Fr 或更高
    • 6Fr 或更少
    • 7Fr～9Fr

第九章：以鞘套尺寸分類的大腿入路装置市场

  • 10Fr 或更高
  • 6Fr 或更少
  • 7Fr～9Fr

第十章：大腿入路器材市场：依材料分类

  • 尼龙
    • 单丝尼龙
    • 多丝纤维龙
  • 聚氨酯
    • 聚酯聚氨酯
    • 醚聚氨酯
  • PTFE
    • 发泡聚四氟乙烯
    • 标准聚四氟乙烯

第十一章：大腿入路装置市场：依应用领域划分

  • 循环系统
    • 诊断性血管造影术
    • 介入性心臟病学
  • 神经病学
    • 神经影像学
    • 介入神经放射学
  • 放射科
    • 诊断放射学
    • 介入放射学
  • 血管外科
    • EVAR
    • 週边血管成形术

第十二章 大腿入路装置市场：依最终用户划分

  • 门诊手术中心
    • 心臟外科手术中心
    • 放射科门诊手术中心
  • 诊所
    • 门诊部
    • 专科诊所
  • 医院
    • 心臟病医院
    • 综合医院

第十三章：大腿入路器材市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 大腿入路器材市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章：大腿入路器材市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章：美国大腿入路器材市场

第十七章：中国大腿入路器材市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Abbott Laboratories
  • AngioDynamics Inc.
  • Argon Medical Devices Inc.
  • B. Braun Melsungen AG
  • Becton Dickinson and Company
  • Boston Scientific Corporation
  • Cardinal Health Inc.
  • Cook Medical LLC
  • Cordis Corporation
  • Edwards Lifesciences Corporation
  • Galt Medical Corp.
  • Lepu Medical Technology Inc.
  • Medikit Co. Ltd.
  • Medline Industries LP
  • Medtronic plc
  • Merit Medical Systems Inc.
  • Nipro Medical Corporation
  • Romsons Scientific & Surgical Pvt. Ltd.
  • Smiths Medical
  • Stryker Corporation
  • Teleflex Incorporated
  • Terumo Corporation
  • Vascular Solutions Inc.
  • Vygon SA
Product Code: MRR-43676CF42AF7

The Femoral Access Devices Market was valued at USD 2.17 billion in 2025 and is projected to grow to USD 2.41 billion in 2026, with a CAGR of 11.49%, reaching USD 4.66 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 2.17 billion
Estimated Year [2026] USD 2.41 billion
Forecast Year [2032] USD 4.66 billion
CAGR (%) 11.49%

A concise orientation to the evolving femoral access devices landscape where clinical demand, device innovation, and operational priorities are shaping strategic choices

The femoral access devices landscape is undergoing a period of sustained evolution as procedural complexity, device innovation, and health system imperatives converge. Clinicians increasingly demand tools that enhance procedural precision while minimizing complications, and manufacturers are adapting product portfolios and materials to meet these expectations. In parallel, evolving reimbursement frameworks, quality metrics, and hospital procurement strategies are shaping purchasing behavior across ambulatory surgical centers, clinics, and hospitals. Consequently, stakeholders across the value chain must reconcile clinical priorities with operational efficiency to deliver improved patient outcomes and reduce peri-procedural morbidity.

Today's clinical decision-making is influenced by a combination of procedural efficacy, device ergonomics, and evidence generated from interventional cardiology, radiology, neurology, and vascular surgery. As a result, product differentiation is less about incremental features and more about demonstrable clinical value, streamlined workflows, and compatibility with a broader ecosystem of interventional equipment. In response, device developers are investing in materials science, hydrophilic coatings, and refined valve and sheath architectures that respond to both clinician preferences and safety imperatives. These advances are creating new expectations for device performance, driving competitive repositioning, and prompting end users to scrutinize total cost of care implications rather than unit price alone.

Looking ahead, market participants must balance innovation with regulatory rigor and supply chain resilience. Clinical adoption will depend on robust evidence, ease of use in variable care settings, and demonstrable reductions in complication rates. Meanwhile, procurement teams will prioritize predictable supply, scalable vendor relationships, and products that enable shorter procedure times and faster patient throughput. This introduction frames a sector in transition, one where strategic investments in product performance, stakeholder engagement, and operational readiness will determine which organizations capture sustainable clinical adoption and payer support.

How clinical practice evolution, polymer and coating innovations, and care setting shifts are redefining device design priorities and procurement behaviors

The femoral access devices sector is experiencing a series of transformative shifts driven by clinical practice changes, technological advances, and heightened emphasis on perioperative safety. Operators are increasingly adopting minimally invasive approaches across cardiology, neurology, radiology, and vascular surgery, which places a premium on smaller profiles, improved hemostasis control, and devices that integrate seamlessly with imaging and guidance systems. As a result, design priorities have shifted toward hydrophilic coatings, adaptable valve systems, and sheath geometries that reduce arterial trauma and support a wider range of procedural instruments.

Simultaneously, material innovation is reshaping product lifecycles. Nylon, polyurethane, and PTFE variants are being reformulated to balance pushability, kink resistance, and biocompatibility. These material optimizations are enabling more reliable introducer sheaths and dilators that perform consistently across diverse patient anatomies. In turn, suppliers are reallocating R&D resources toward polymer chemistry and coating technologies that can deliver both tactile responsiveness and reduced complication rates. The emergence of multi-lumen dilators and specialized guidewire tip configurations reflects an ongoing trend toward task-specific instruments that enhance procedural control and reduce exchange-related risks.

Operationally, the shift toward ambulatory and hybrid care settings is prompting changes in device distribution and service models. Ambulatory surgical centers and outpatient specialty clinics demand kits and device bundles that simplify inventory management and reduce setup time. Consequently, manufacturers are exploring value-added services such as vendor-managed inventory, surgical training programs, and digital tools for device tracking and clinical outcomes monitoring. These shifts are also encouraging strategic partnerships between device companies and healthcare providers to co-develop protocols that standardize access strategies and promote consistent outcomes. As these trends coalesce, the competitive landscape will favor organizations that can demonstrate clinical effectiveness, operational convenience, and an ability to reduce overall peri-procedural risk.

Assessment of how evolving tariff policies and trade dynamics in 2025 are reshaping sourcing strategies, pricing negotiations, and supply chain resilience decisions

In 2025, changes in trade policy and tariff implementations have introduced new layers of complexity for organizations sourcing femoral access devices and components. Tariff adjustments targeting medical device imports, components, and raw polymer inputs have altered cost structures for certain manufacturers and distributors, particularly those with supply chains oriented toward cross-border manufacturing hubs. These shifts have compelled downstream stakeholders to reassess sourcing strategies, inventory buffers, and supplier diversification to mitigate exposure to sudden cost transference.

For manufacturers that import critical materials such as specialized polymers, PTFE variants, and hydrophilic coating chemicals, tariffs have translated into higher input costs and, in some cases, a re-evaluation of production footprints. As a result, several firms are accelerating nearshoring initiatives and vendor consolidation to preserve margin and reduce lead-time variability. At the same time, procurement teams within hospitals and ambulatory surgical centers are pushing for greater transparency around landed costs and total cost of ownership, challenging suppliers to provide clearer breakdowns of price drivers and to demonstrate cost-saving value across the care continuum.

The cumulative impact has also influenced strategic pricing and contract negotiations. Large integrated health systems are leveraging purchasing scale to seek fixed-price multi-year agreements that hedge against further tariff volatility, while smaller providers are prioritizing flexible procurement arrangements that allow for rapid substitution or switching to alternative product lines. Moreover, the tariff environment has accelerated conversation around product localization, with some original equipment manufacturers investing in regional manufacturing capabilities to reduce tariff exposure and improve supply chain resilience. These changes are prompting legal, regulatory, and commercial teams to collaborate more closely to align sourcing decisions with evolving trade conditions and to protect continuity of care.

High-resolution segmentation analysis revealing how device architecture, sheath dimensions, clinical application, end-user setting, and material science collectively drive adoption

Understanding segment-level performance requires a granular look at device categories, sheath dimensions, clinical applications, end-user settings, and material selection, each of which drives distinct purchasing logic and clinical value propositions. Based on device type, the market is studied across dilator, guidewire, hemostasis valve, and introducer sheath; within dilators, the distinction between multi-lumen and single lumen configurations informs exchange efficiency and device compatibility, while guidewire subtypes such as hydrophilic coated, J tip, and straight tip determine navigation characteristics and vessel access strategy. Hemostasis valve options ranging from hydrophilic valves to mechanical valves directly affect blood loss management and procedural ergonomics, and introducer sheaths segmented into 10Fr & above, 6Fr & below, and 7Fr-9Fr reflect procedural instrument compatibility and vessel trauma considerations.

Sheath size segmentation similarly frames clinical decision-making; 10Fr & above profiles are often selected for complex interventional procedures requiring larger device platforms, whereas 6Fr & below profiles support diagnostic angiography and less invasive interventions, with 7Fr-9Fr representing a compromise between access trauma and device compatibility. Application-based segmentation highlights the interplay between device features and clinical workflows across cardiology, neurology, radiology, and vascular surgery. Cardiology use encompasses diagnostic angiography and interventional cardiology where rapid hemostasis and sheath maneuverability are prioritized. Neurology covers neuroimaging and neurointervention, emphasizing atraumatic navigation and compatibility with neurovascular devices. Radiology spans diagnostic and interventional radiology with diverse sheath and guidewire requirements, and vascular surgery includes EVAR and peripheral angioplasty procedures where device robustness and seal integrity are critical.

End-user segmentation differentiates adoption dynamics across ambulatory surgical centers, clinics, and hospitals. Ambulatory surgical centers are further profiled into cardiac and radiology ASCs that demand streamlined kits and predictable supply, clinics are split into outpatient and specialty clinics that prioritize cost-effectiveness and ease of use, and hospitals are categorized into cardiac hospitals and multispecialty hospitals where procurement decisions balance volume-based contracts with clinical trial-driven adoption. Material segmentation captures the role of polymer science in device performance. Nylon variants, including monofilament and multifilament forms, offer differing tensile properties and tactile feedback. Polyurethane subtypes such as ester and ether formulations balance flexibility and chemical resistance, while PTFE options, comprising expanded and standard PTFE, contribute to lubricity and reduced friction. Together, these segmentations reveal how product architecture, sizing, clinical context, care setting, and material properties jointly determine specification choices, purchasing criteria, and adoption curves.

Regional dynamics and strategic considerations showing how distinct reimbursement, regulatory, and infrastructure factors are influencing adoption across key global regions

Regional dynamics in the femoral access devices sector reflect divergent healthcare system structures, regulatory environments, and investment priorities across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, established interventional cardiology and vascular surgery programs paired with robust reimbursement frameworks support early adoption of advanced device features and bundled service models. This region's focus on clinical outcomes and value-based procurement encourages suppliers to demonstrate reductions in complication rates and to support long-term clinical studies that validate device performance in real-world settings.

Across Europe, the Middle East & Africa, regulatory harmonization efforts and public procurement mechanisms shape purchasing cycles and product registration strategies. Hospitals and health authorities in many markets emphasize cost containment and standardized device formularies, fostering demand for devices that combine clinical efficacy with demonstrable cost benefits. In addition, regional centers of excellence in interventional neurology and radiology drive innovation adoption in higher-acuity sites, influencing vendor positioning and partnership models.

The Asia-Pacific region is characterized by heterogeneous market maturity and rapid capacity expansion in diagnostic and interventional services. Investments in new hospital infrastructure, growth in ambulatory surgical centers, and a rising prevalence of cardiovascular and neurovascular procedures are motivating accelerated uptake of femoral access technologies. Meanwhile, local manufacturing capabilities and policy incentives for domestic production are prompting multinational firms to adapt supply chain footprints and to pursue collaborative ventures. Collectively, these regional trends shape how suppliers prioritize product launches, clinical education programs, and commercial strategies to meet diverse regulatory and end-user expectations.

Competitive landscape insights detailing how innovation in coatings, valve design, and integrated service offerings are shaping vendor differentiation and alliances

Competitive positioning in the femoral access devices arena is being redefined by product innovation, strategic partnerships, and a renewed emphasis on supply continuity. Leading device developers are prioritizing differentiated technologies-such as advanced hydrophilic coatings, refined hemostasis valve designs, and sheath geometries optimized for reduced arterial trauma-to secure preference among interventionalists. Many firms are also expanding their service portfolios to include surgeon training, procedural checklists, and data-driven outcomes support that facilitate adoption and reinforce clinical value propositions.

Strategic collaborations between device manufacturers and clinical centers are increasingly common, enabling co-development of protocolized access approaches and post-market surveillance programs. These alliances help demonstrate real-world performance while creating pathways for incremental product enhancement. At the same time, some companies are pursuing operational initiatives to shore up manufacturing resilience, including localized production and diversified supplier relationships for critical polymers and coating chemistries. Such measures are essential to mitigate supply disruptions and to preserve contract commitments under evolving tariff regimes.

Finally, the competitive landscape is shaped by the capacity to provide integrated solutions that reduce hospital inventory complexity and improve procedural throughput. Organizations that can bundle compatible dilators, guidewires, hemostasis valves, and sheaths into clinician-friendly kits, while supporting them with training and outcomes data, are likely to secure stronger in-market traction. Success will hinge on demonstrating that these integrated offerings deliver measurable improvements in procedural efficiency, safety, and clinician satisfaction.

Actionable strategic priorities to synchronize product innovation, manufacturing resilience, clinician engagement, and flexible contracting to secure durable market leadership

Industry leaders should pursue a coordinated strategy that aligns product innovation with supply chain resilience and clinical outcomes evidence. First, prioritize investments in materials and coating technologies that demonstrably reduce vascular trauma and improve device handling, and couple those innovations with rigorous post-market data collection to validate clinical benefits. Demonstrating reduced complication rates and workflow efficiencies will be pivotal when engaging with outcome-focused procurement committees and payer stakeholders.

Second, diversify manufacturing footprints and secure alternative suppliers for critical raw materials to reduce exposure to tariff-driven cost volatility and geopolitical disruptions. Nearshoring or regional manufacturing partnerships can shorten lead times and support longer-term commercial contracts with large health systems. Third, develop clinician-centric delivery models by offering procedure-specific kits, hands-on training programs, and digital tools that track device utilization and clinical outcomes. These initiatives will lower the barriers to adoption in ambulatory and outpatient settings while building long-term clinician loyalty.

Fourth, emphasize commercial flexibility by offering tiered pricing, multi-year supply agreements, and outcome-linked contracting where feasible. This will enable purchasers to manage cost uncertainty and to align incentives across stakeholders. Finally, invest in targeted regional strategies that respect local regulatory dynamics and care delivery models; in some regions this will require partnerships with domestic manufacturers or tailored clinical evidence packages that speak to regional practice patterns. By executing on these priorities, industry leaders can strengthen market positioning, protect margins, and expand clinical adoption across diverse care settings.

Robust mixed-methods research approach combining clinician interviews, regulatory and clinical evidence review, and scenario analysis to produce validated strategic insights

This research synthesizes multiple streams of evidence to ensure conclusions are grounded in both primary insight and secondary validation. Primary inputs include structured interviews with interventional clinicians across cardiology, neurology, radiology, and vascular surgery, procurement and supply chain leaders at hospitals and ambulatory centers, and R&D executives at device manufacturers. These engagements were designed to elicit practical perspectives on device performance, procurement priorities, clinical workflow constraints, and supply chain sensitivities.

Secondary research encompassed a systematic review of peer-reviewed clinical literature, regulatory approvals and safety communications, patent filings, and publicly available corporate disclosures that illuminate product pipelines and commercial strategies. Where available, clinical registries and procedure outcome repositories were consulted to triangulate claims regarding device safety and efficacy. The methodology emphasized cross-validation between clinician-reported experiences and documented clinical evidence to reduce bias and improve the reliability of insights.

Analytic techniques included comparative feature mapping across device segments, scenario analysis for tariff and supply chain impacts, and qualitative synthesis to derive actionable recommendations. Care was taken to maintain transparency around data sources and to qualify insights where evidence was limited or evolving. This approach ensures that findings are both actionable for commercial stakeholders and sufficiently rigorous for clinical audiences seeking evidence-aligned guidance.

Synthesis of core findings and a strategic roadmap emphasizing clinical validation, supply chain agility, and commercial alignment to drive sustained adoption

The femoral access devices landscape is at an inflection point where technical refinement, clinical priorities, and commercial strategy intersect. Advances in materials and device architecture are enabling safer, more efficient access techniques, while changing care settings and procurement models are reshaping how devices are purchased and deployed. At the same time, trade policy developments and supply chain pressures underscore the need for manufacturing agility and commercial flexibility.

Success in this environment will depend on a disciplined focus on three intertwined objectives: delivering measurable clinical value through innovation and evidence generation, securing supply chain robustness to ensure uninterrupted access to critical components, and aligning commercial models with purchaser expectations around outcomes and total cost of care. Organizations that can operationalize these objectives-by combining product differentiation with clinician engagement and flexible contracting-will be best positioned to capture sustained adoption across hospitals, ambulatory centers, and specialty clinics. The recommendations offered herein provide a practical roadmap to navigate the near-term challenges and to capitalize on long-term opportunities within the sector.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Femoral Access Devices Market, by Device Type

  • 8.1. Dilator
    • 8.1.1. Multi-Lumen
    • 8.1.2. Single Lumen
  • 8.2. Guidewire
    • 8.2.1. Hydrophilic Coated
    • 8.2.2. J Tip
    • 8.2.3. Straight Tip
  • 8.3. Hemostasis Valve
    • 8.3.1. Hydrophilic Valve
    • 8.3.2. Mechanical Valve
  • 8.4. Introducer Sheath
    • 8.4.1. 10Fr & Above
    • 8.4.2. 6Fr & Below
    • 8.4.3. 7Fr-9Fr

9. Femoral Access Devices Market, by Sheath Size

  • 9.1. 10Fr & Above
  • 9.2. 6Fr & Below
  • 9.3. 7Fr-9Fr

10. Femoral Access Devices Market, by Material

  • 10.1. Nylon
    • 10.1.1. Monofilament Nylon
    • 10.1.2. Multifilament Nylon
  • 10.2. Polyurethane
    • 10.2.1. Ester Polyurethane
    • 10.2.2. Ether Polyurethane
  • 10.3. PTFE
    • 10.3.1. Expanded PTFE
    • 10.3.2. Standard PTFE

11. Femoral Access Devices Market, by Application

  • 11.1. Cardiology
    • 11.1.1. Diagnostic Angiography
    • 11.1.2. Interventional Cardiology
  • 11.2. Neurology
    • 11.2.1. Neuroimaging
    • 11.2.2. Neurointervention
  • 11.3. Radiology
    • 11.3.1. Diagnostic Radiology
    • 11.3.2. Interventional Radiology
  • 11.4. Vascular Surgery
    • 11.4.1. EVAR
    • 11.4.2. Peripheral Angioplasty

12. Femoral Access Devices Market, by End User

  • 12.1. Ambulatory Surgical Center
    • 12.1.1. Cardiac ASC
    • 12.1.2. Radiology ASC
  • 12.2. Clinic
    • 12.2.1. Outpatient Clinic
    • 12.2.2. Specialty Clinic
  • 12.3. Hospital
    • 12.3.1. Cardiac Hospital
    • 12.3.2. Multispecialty Hospital

13. Femoral Access Devices Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Femoral Access Devices Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Femoral Access Devices Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Femoral Access Devices Market

17. China Femoral Access Devices Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Abbott Laboratories
  • 18.6. AngioDynamics Inc.
  • 18.7. Argon Medical Devices Inc.
  • 18.8. B. Braun Melsungen AG
  • 18.9. Becton Dickinson and Company
  • 18.10. Boston Scientific Corporation
  • 18.11. Cardinal Health Inc.
  • 18.12. Cook Medical LLC
  • 18.13. Cordis Corporation
  • 18.14. Edwards Lifesciences Corporation
  • 18.15. Galt Medical Corp.
  • 18.16. Lepu Medical Technology Inc.
  • 18.17. Medikit Co. Ltd.
  • 18.18. Medline Industries LP
  • 18.19. Medtronic plc
  • 18.20. Merit Medical Systems Inc.
  • 18.21. Nipro Medical Corporation
  • 18.22. Romsons Scientific & Surgical Pvt. Ltd.
  • 18.23. Smiths Medical
  • 18.24. Stryker Corporation
  • 18.25. Teleflex Incorporated
  • 18.26. Terumo Corporation
  • 18.27. Vascular Solutions Inc.
  • 18.28. Vygon SA

LIST OF FIGURES

  • FIGURE 1. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL FEMORAL ACCESS DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL FEMORAL ACCESS DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY SHEATH SIZE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES FEMORAL ACCESS DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA FEMORAL ACCESS DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY DILATOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY DILATOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY DILATOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY DILATOR, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY MULTI-LUMEN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY MULTI-LUMEN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY MULTI-LUMEN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY SINGLE LUMEN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY SINGLE LUMEN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY SINGLE LUMEN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY GUIDEWIRE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY GUIDEWIRE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY GUIDEWIRE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY GUIDEWIRE, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY HYDROPHILIC COATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY HYDROPHILIC COATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY HYDROPHILIC COATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY J TIP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY J TIP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY J TIP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY STRAIGHT TIP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY STRAIGHT TIP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY STRAIGHT TIP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY HEMOSTASIS VALVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY HEMOSTASIS VALVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY HEMOSTASIS VALVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY HEMOSTASIS VALVE, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY HYDROPHILIC VALVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY HYDROPHILIC VALVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY HYDROPHILIC VALVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY MECHANICAL VALVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY MECHANICAL VALVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY MECHANICAL VALVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY INTRODUCER SHEATH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY INTRODUCER SHEATH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY INTRODUCER SHEATH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY INTRODUCER SHEATH, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY 10FR & ABOVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY 10FR & ABOVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY 10FR & ABOVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY 6FR & BELOW, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY 6FR & BELOW, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY 6FR & BELOW, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY 7FR-9FR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY 7FR-9FR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY 7FR-9FR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY SHEATH SIZE, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY 10FR & ABOVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY 10FR & ABOVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY 10FR & ABOVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY 6FR & BELOW, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY 6FR & BELOW, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY 6FR & BELOW, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY 7FR-9FR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY 7FR-9FR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY 7FR-9FR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY NYLON, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY NYLON, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY NYLON, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY NYLON, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY MONOFILAMENT NYLON, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY MONOFILAMENT NYLON, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY MONOFILAMENT NYLON, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY MULTIFILAMENT NYLON, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY MULTIFILAMENT NYLON, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY MULTIFILAMENT NYLON, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY POLYURETHANE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY POLYURETHANE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY POLYURETHANE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY POLYURETHANE, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY ESTER POLYURETHANE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY ESTER POLYURETHANE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY ESTER POLYURETHANE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY ETHER POLYURETHANE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY ETHER POLYURETHANE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY ETHER POLYURETHANE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY PTFE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY PTFE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY PTFE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY PTFE, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY EXPANDED PTFE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY EXPANDED PTFE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY EXPANDED PTFE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY STANDARD PTFE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY STANDARD PTFE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY STANDARD PTFE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY CARDIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY DIAGNOSTIC ANGIOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY DIAGNOSTIC ANGIOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY DIAGNOSTIC ANGIOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY INTERVENTIONAL CARDIOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY INTERVENTIONAL CARDIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY INTERVENTIONAL CARDIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY NEUROLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY NEUROIMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY NEUROIMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY NEUROIMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY NEUROINTERVENTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY NEUROINTERVENTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY NEUROINTERVENTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY RADIOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY RADIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY RADIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY RADIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY DIAGNOSTIC RADIOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY DIAGNOSTIC RADIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY DIAGNOSTIC RADIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY INTERVENTIONAL RADIOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY INTERVENTIONAL RADIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY INTERVENTIONAL RADIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY VASCULAR SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY VASCULAR SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY VASCULAR SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY VASCULAR SURGERY, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY EVAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY EVAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY EVAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY PERIPHERAL ANGIOPLASTY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY PERIPHERAL ANGIOPLASTY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY PERIPHERAL ANGIOPLASTY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY CARDIAC ASC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY CARDIAC ASC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY CARDIAC ASC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY RADIOLOGY ASC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY RADIOLOGY ASC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY RADIOLOGY ASC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY CLINIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY CLINIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY CLINIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY CLINIC, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY OUTPATIENT CLINIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY OUTPATIENT CLINIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 148. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY OUTPATIENT CLINIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY SPECIALTY CLINIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 150. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY SPECIALTY CLINIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 151. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY SPECIALTY CLINIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 152. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 153. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 154. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 156. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY CARDIAC HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 157. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY CARDIAC HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 158. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY CARDIAC HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 159. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY MULTISPECIALTY HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 160. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY MULTISPECIALTY HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 161. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY MULTISPECIALTY HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 162. GLOBAL FEMORAL ACCESS DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 163. AMERICAS FEMORAL ACCESS DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 164. AMERICAS FEMORAL ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. AMERICAS FEMORAL ACCESS DEVICES MARKET SIZE, BY DILATOR, 2018-2032 (USD MILLION)
  • TABLE 166. AMERICAS FEMORAL ACCESS DEVICES MARKET SIZE, BY GUIDEWIRE, 2018-2032 (USD MILLION)
  • TABLE 167. AMERICAS FEMORAL ACCESS DEVICES MARKET SIZE, BY HEMOSTASIS VALVE, 2018-2032 (USD MILLION)
  • TABLE 168. AMERICAS FEMORAL ACCESS DEVICES MARKET SIZE, BY INTRODUCER SHEATH, 2018-2032 (USD MILLION)
  • TABLE 169. AMERICAS FEMORAL ACCESS DEVICES MARKET SIZE, BY SHEATH SIZE, 2018-2032 (USD MILLION)
  • TABLE 170. AMERICAS FEMORAL ACCESS DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 171. AMERICAS FEMORAL ACCESS DEVICES MARKET SIZE, BY NYLON, 2018-2032 (USD MILLION)
  • TABLE 172. AMERICAS FEMORAL ACCESS DEVICES MARKET SIZE, BY POLYURETHANE, 2018-2032 (USD MILLION)
  • TABLE 173. AMERICAS FEMORAL ACCESS DEVICES MARKET SIZE, BY PTFE, 2018-2032 (USD MILLION)
  • TABLE 174. AMERICAS FEMORAL ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 175. AMERICAS FEMORAL ACCESS DEVICES MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 176. AMERICAS FEMORAL ACCESS DEVICES MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 177. AMERICAS FEMORAL ACCESS DEVICES MARKET SIZE, BY RADIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 178. AMERICAS FEMORAL ACCESS DEVICES MARKET SIZE, BY VASCULAR SURGERY, 2018-2032 (USD MILLION)
  • TABLE 179. AMERICAS FEMORAL ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 180. AMERICAS FEMORAL ACCESS DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, 2018-2032 (USD MILLION)
  • TABLE 181. AMERICAS FEMORAL ACCESS DEVICES MARKET SIZE, BY CLINIC, 2018-2032 (USD MILLION)
  • TABLE 182. AMERICAS FEMORAL ACCESS DEVICES MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 183. NORTH AMERICA FEMORAL ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 184. NORTH AMERICA FEMORAL ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. NORTH AMERICA FEMORAL ACCESS DEVICES MARKET SIZE, BY DILATOR, 2018-2032 (USD MILLION)
  • TABLE 186. NORTH AMERICA FEMORAL ACCESS DEVICES MARKET SIZE, BY GUIDEWIRE, 2018-2032 (USD MILLION)
  • TABLE 187. NORTH AMERICA FEMORAL ACCESS DEVICES MARKET SIZE, BY HEMOSTASIS VALVE, 2018-2032 (USD MILLION)
  • TABLE 188. NORTH AMERICA FEMORAL ACCESS DEVICES MARKET SIZE, BY INTRODUCER SHEATH, 2018-2032 (USD MILLION)
  • TABLE 189. NORTH AMERICA FEMORAL ACCESS DEVICES MARKET SIZE, BY SHEATH SIZE, 2018-2032 (USD MILLION)
  • TABLE 190. NORTH AMERICA FEMORAL ACCESS DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 191. NORTH AMERICA FEMORAL ACCESS DEVICES MARKET SIZE, BY NYLON, 2018-2032 (USD MILLION)
  • TABLE 192. NORTH AMERICA FEMORAL ACCESS DEVICES MARKET SIZE, BY POLYURETHANE, 2018-2032 (USD MILLION)
  • TABLE 193. NORTH AMERICA FEMORAL ACCESS DEVICES MARKET SIZE, BY PTFE, 2018-2032 (USD MILLION)
  • TABLE 194. NORTH AMERICA FEMORAL ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 195. NORTH AMERICA FEMORAL ACCESS DEVICES MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 196. NORTH AMERICA FEMORAL ACCESS DEVICES MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 197. NORTH AMERICA FEMORAL ACCESS DEVICES MARKET SIZE, BY RADIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 198. NORTH AMERICA FEMORAL ACCESS DEVICES MARKET SIZE, BY VASCULAR SURGERY, 2018-2032 (USD MILLION)
  • TABLE 199. NORTH AMERICA FEMORAL ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 200. NORTH AMERICA FEMORAL ACCESS DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, 2018-2032 (USD MILLION)
  • TABLE 201. NORTH AMERICA FEMORAL ACCESS DEVICES MARKET SIZE, BY CLINIC, 2018-2032 (USD MILLION)
  • TABLE 202. NORTH AMERICA FEMORAL ACCESS DEVICES MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 203. LATIN AMERICA FEMORAL ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 204. LATIN AMERICA FEMORAL ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 205. LATIN AMERICA FEMORAL ACCESS DEVICES MARKET SIZE, BY DILATOR, 2018-2032 (USD MILLION)
  • TABLE 206. LATIN AMERICA FEMORAL ACCESS DEVICES MARKET SIZE, BY GUIDEWIRE, 2018-2032 (USD MILLION)
  • TABLE 207. LATIN AMERICA FEMORAL ACCESS DEVICES MARKET SIZE, BY HEMOSTASIS VALVE, 2018-2032 (USD MILLION)
  • TABLE 208. LATIN AMERICA FEMORAL ACCESS DEVICES MARKET SIZE, BY INTRODUCER SHEATH, 2018-2032 (USD MILLION)
  • TABLE 209. LATIN AMERICA FEMORAL ACCESS DEVICES MARKET SIZE, BY SHEATH SIZE, 2018-2032 (USD MILLION)
  • TABLE 210. LATIN AMERICA FEMORAL ACCESS DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 211. LATIN AMERICA FEMORAL ACCESS DEVICES MARKET SIZE, BY NYLON, 2018-2032 (USD MILLION)
  • TABLE 212. LATIN AMERICA FEMORAL ACCESS DEVICES MARKET SIZE, BY POLYURETHANE, 2018-2032 (USD MILLION)
  • TABLE 213. LATIN AMERICA FEMORAL ACCESS DEVICES MARKET SIZE, BY PTFE, 2018-2032 (USD MILLION)
  • TABLE 214. LATIN AMERICA FEMORAL ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 215. LATIN AMERICA FEMORAL ACCESS DEVICES MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 216. LATIN AMERICA FEMORAL ACCESS DEVICES MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 217. LATIN AMERICA FEMORAL ACCESS DEVICES MARKET SIZE, BY RADIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 218. LATIN AMERICA FEMORAL ACCESS DEVICES MARKET SIZE, BY VASCULAR SURGERY, 2018-2032 (USD MILLION)
  • TABLE 219. LATIN AMERICA FEMORAL ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 220. LATIN AMERICA FEMORAL ACCESS DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, 2018-2032 (USD MILLION)
  • TABLE 221. LATIN AMERICA FEMORAL ACCESS DEVICES MARKET SIZE, BY CLINIC, 2018-2032 (USD MILLION)
  • TABLE 222. LATIN AMERICA FEMORAL ACCESS DEVICES MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPE, MIDDLE EAST & AFRICA FEMORAL ACCESS DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPE, MIDDLE EAST & AFRICA FEMORAL ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 225. EUROPE, MIDDLE EAST & AFRICA FEMORAL ACCESS DEVICES MARKET SIZE, BY DILATOR, 2018-2032 (USD MILLION)
  • TABLE 226. EUROPE, MIDDLE EAST & AFRICA FEMORAL ACCESS DEVICES MARKET SIZE, BY GUIDEWIRE, 2018-2032 (USD MILLION)
  • TABLE 227. EUROPE, MIDDLE EAST & AFRICA FEMORAL ACCESS DEVICES MARKET SIZE, BY HEMOSTASIS VALVE, 2018-2032 (USD MILLION)
  • TABLE 228. EUROPE, MIDDLE EAST & AFRICA FEMORAL ACCESS DEVICES MARKET SIZE, BY INTRODUCER SHEATH, 2018-2032 (USD MILLION)
  • TABLE 229. EUROPE, MIDDLE EAST & AFRICA FEMORAL ACCESS DEVICES MARKET SIZE, BY SHEATH SIZE, 2018-2032 (USD MILLION)
  • TABLE 230. EUROPE, MIDDLE EAST & AFRICA FEMORAL ACCESS DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 231. EUROPE, MIDDLE EAST & AFRICA FEMORAL ACCESS DEVICES MARKET SIZE, BY NYLON, 2018-2032 (USD MILLION)
  • TABLE 232. EUROPE, MIDDLE EAST & AFRICA FEMORAL ACCESS DEVICES MARKET SIZE, BY POLYURETHANE, 2018-2032 (USD MILLION)
  • TABLE 233. EUROPE, MIDDLE EAST & AFRICA FEMORAL ACCESS DEVICES MARKET SIZE, BY PTFE, 2018-2032 (USD MILLION)
  • TABLE 234. EUROPE, MIDDLE EAST & AFRICA FEMORAL ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 235. EUROPE, MIDDLE EAST & AFRICA FEMORAL ACCESS DEVICES MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 236. EUROPE, MIDDLE EAST & AFRICA FEMORAL ACCESS DEVICES MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 237. EUROPE, MIDDLE EAST & AFRICA FEMORAL ACCESS DEVICES MARKET SIZE, BY RADIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 238. EUROPE, MIDDLE EAST & AFRICA FEMORAL ACCESS DEVICES MARKET SIZE, BY VASCULAR SURGERY, 2018-2032 (USD MILLION)
  • TABLE 239. EUROPE, MIDDLE EAST & AFRICA FEMORAL ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 240. EUROPE, MIDDLE EAST & AFRICA FEMORAL ACCESS DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, 2018-2032 (USD MILLION)
  • TABLE 241. EUROPE, MIDDLE EAST & AFRICA FEMORAL ACCESS DEVICES MARKET SIZE, BY CLINIC, 2018-2032 (USD MILLION)
  • TABLE 242. EUROPE, MIDDLE EAST & AFRICA FEMORAL ACCESS DEVICES MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 243. EUROPE FEMORAL ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 244. EUROPE FEMORAL ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 245. EUROPE FEMORAL ACCESS DEVICES MARKET SIZE, BY DILATOR, 2018-2032 (USD MILLION)
  • TABLE 246. EUROPE FEMORAL ACCESS DEVICES MARKET SIZE, BY GUIDEWIRE, 2018-2032 (USD MILLION)
  • TABLE 247. EUROPE FEMORAL ACCESS DEVICES MARKET SIZE, BY HEMOSTASIS VALVE, 2018-2032 (USD MILLION)
  • TABLE 248. EUROPE FEMORAL ACCESS DEVICES MARKET SIZE, BY INTRODUCER SHEATH, 2018-2032 (USD MILLION)
  • TABLE 249. EUROPE FEMORAL ACCESS DEVICES MARKET SIZE, BY SHEATH SIZE, 2018-2032 (USD MILLION)
  • TABLE 250. EUROPE FEMORAL ACCESS DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 251. EUROPE FEMORAL ACCESS DEVICES MARKET SIZE, BY NYLON, 2018-2032 (USD MILLION)
  • TABLE 252. EUROPE FEMORAL ACCESS DEVICES MARKET SIZE, BY POLYURETHANE, 2018-2032 (USD MILLION)
  • TABLE 253. EUROPE FEMORAL ACCESS DEVICES MARKET SIZE, BY PTFE, 2018-2032 (USD MILLION)
  • TABLE 254. EUROPE FEMORAL ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 255. EUROPE FEMORAL ACCESS DEVICES MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 256. EUROPE FEMORAL ACCESS DEVICES MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 257. EUROPE FEMORAL ACCESS DEVICES MARKET SIZE, BY RADIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 258. EUROPE FEMORAL ACCESS DEVICES MARKET SIZE, BY VASCULAR SURGERY, 2018-2032 (USD MILLION)
  • TABLE 259. EUROPE FEMORAL ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 260. EUROPE FEMORAL ACCESS DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, 2018-2032 (USD MILLION)
  • TABLE 261. EUROPE FEMORAL ACCESS DEVICES MARKET SIZE, BY CLINIC, 2018-2032 (USD MILLION)
  • TABLE 262. EUROPE FEMORAL ACCESS DEVICES MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 263. MIDDLE EAST FEMORAL ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 264. MIDDLE EAST FEMORAL ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 265. MIDDLE EAST FEMORAL ACCESS DEVICES MARKET SIZE, BY DILATOR, 2018-2032 (USD MILLION)
  • TABLE 266. MIDDLE EAST FEMORAL ACCESS DEVICES MARKET SIZE, BY GUIDEWIRE, 2018-2032 (USD MILLION)
  • TABLE 267. MIDDLE EAST FEMORAL ACCESS DEVICES MARKET SIZE, BY HEMOSTASIS VALVE, 2018-2032 (USD MILLION)
  • TABLE 268. MIDDLE EAST FEMORAL ACCESS DEVICES MARKET SIZE, BY INTRODUCER SHEATH, 2018-2032 (USD MILLION)
  • TABLE 269. MIDDLE EAST FEMORAL ACCESS DEVICES MARKET SIZE, BY SHEATH SIZE, 2018-2032 (USD MILLION)
  • TABLE 270. MIDDLE EAST FEMORAL ACCESS DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 271. MIDDLE EAST FEMORAL ACCESS DEVICES MARKET SIZE, BY NYLON, 2018-2032 (USD MILLION)
  • TABLE 272. MIDDLE EAST FEMORAL ACCESS DEVICES MARKET SIZE, BY POLYURETHANE, 2018-2032 (USD MILLION)
  • TABLE 273. MIDDLE EAST FEMORAL ACCESS DEVICES MARKET SIZE, BY PTFE, 2018-2032 (USD MILLION)
  • TABLE 274. MIDDLE EAST FEMORAL ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 275. MIDDLE EAST FEMORAL ACCESS DEVICES MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 276. MIDDLE EAST FEMORAL ACCESS DEVICES MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 277. MIDDLE EAST FEMORAL ACCESS DEVICES MARKET SIZE, BY RADIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 278. MIDDLE EAST FEMORAL ACCESS DEVICES MARKET SIZE, BY VASCULAR SURGERY, 2018-2032 (USD MILLION)
  • TABLE 279. MIDDLE EAST FEMORAL ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 280. MIDDLE EAST FEMORAL ACCESS DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, 2018-2032 (USD MILLION)
  • TABLE 281. MIDDLE EAST FEMORAL ACCESS DEVICES MARKET SIZE, BY CLINIC, 2018-2032 (USD MILLION)
  • TABLE 282. MIDDLE EAST FEMORAL ACCESS DEVICES MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 283. AFRICA FEMORAL ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 284. AFRICA FEMORAL ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 285. AFRICA FEMORAL ACCESS DEVICES MARKET SIZE, BY DILATOR, 2018-2032 (USD MILLION)
  • TABLE 286. AFRICA FEMORAL ACCESS DEVICES MARKET SIZE, BY GUIDEWIRE, 2018-2032 (USD MILLION)
  • TABLE 287. AFRICA FEMORAL ACCESS DEVICES MARKET SIZE, BY HEMOSTASIS VALVE, 2018-2032 (USD MILLION)
  • TABLE 288. AFRICA FEMORAL ACCESS DEVICES MARKET SIZE, BY INTRODUCER SHEATH, 2018-2032 (USD MILLION)
  • TABLE 289. AFRICA FEMORAL ACCESS DEVICES MARKET SIZE, BY SHEATH SIZE, 2018-2032 (USD MILLION)
  • TABLE 290. AFRICA FEMORAL ACCESS DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 291. AFRICA FEMORAL ACCESS DEVICES MARKET SIZE, BY NYLON, 2018-2032 (USD MILLION)
  • TABLE 292. AFRICA FEMORAL ACCESS DEVICES MARKET SIZE, BY POLYURETHANE, 2018-2032 (USD MILLION)
  • TABLE 293. AFRICA FEMORAL ACCESS DEVICES MARKET SIZE, BY PTFE, 2018-2032 (USD MILLION)
  • TABLE 294. AFRICA FEMORAL ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 295. AFRICA FEMORAL ACCESS DEVICES MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 296. AFRICA FEMORAL ACCESS DEVICES MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 297. AFRICA FEMORAL ACCESS DEVICES MARKET SIZE, BY RADIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 298. AFRICA FEMORAL ACCESS DEVICES MARKET SIZE, BY VASCULAR SURGERY, 2018-2032 (USD MILLION)
  • TABLE 299. AFRICA FEMORAL ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 300. AFRICA FEMORAL ACCESS DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, 2018-2032 (USD MILLION)
  • TABLE 301. AFRICA FEMORAL ACCESS DEVICES MARKET SIZE, BY CLINIC, 2018-2032 (USD MILLION)
  • TABLE 302. AFRICA FEMORAL ACCESS DEVICES MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 303. ASIA-PACIFIC FEMORAL ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 304. ASIA-PACIFIC FEMORAL ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 305. ASIA-PACIFIC FEMORAL ACCESS DEVICES MARKET SIZE, BY DILATOR, 2018-2032 (USD MILLION)
  • TABLE 306. ASIA-PACIFIC FEMORAL ACCESS DEVICES MARKET SIZE, BY GUIDEWIRE, 2018-2032 (USD MILLION)
  • TABLE 307. ASIA-PACIFIC FEMORAL ACCESS DEVICES MARKET SIZE, BY HEMOSTASIS VALVE, 2018-2032 (USD MILLION)
  • TABLE 308. ASIA-PACIFIC FEMORAL ACCESS DEVICES MARKET SIZE, BY INTRODUCER SHEATH, 2018-2032 (USD MILLION)
  • TABLE 309. ASIA-PACIFIC FEMORAL ACCESS DEVICES MARKET SIZE, BY SHEATH SIZE, 2018-2032 (USD MILLION)
  • TABLE 310. ASIA-PACIFIC FEMORAL ACCESS DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 311. ASIA-PACIFIC FEMORAL ACCESS DEVICES MARKET SIZE, BY NYLON, 2018-2032 (USD MILLION)
  • TABLE 312. ASIA-PACIFIC FEMORAL ACCESS DEVICES MARKET SIZE, BY POLYURETHANE, 2018-2032 (USD MILLION)
  • TABLE 313. ASIA-PACIFIC FEMORAL ACCESS DEVICES MARKET SIZE, BY PTFE, 2018-2032 (USD MILLION)
  • TABLE 314. ASIA-PACIFIC FEMORAL ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 315. ASIA-PACIFIC FEMORAL ACCESS DEVICES MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 316. ASIA-PACIFIC FEMORAL ACCESS DEVICES MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 317. ASIA-PACIFIC FEMORAL ACCESS DEVICES MARKET SIZE, BY RADIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 318. ASIA-PACIFIC FEMORAL ACCESS DEVICES MARKET SIZE, BY VASCULAR SURGERY, 2018-2032 (USD MILLION)
  • TABLE 319. ASIA-PACIFIC FEMORAL ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 320. ASIA-PACIFIC FEMORAL ACCESS DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, 2018-2